Welcome to our dedicated page for Sharecare news (Ticker: SHCR), a resource for investors and traders seeking the latest updates and insights on Sharecare stock.
Sharecare Inc (SHCR) is a leading digital health innovator providing unified health management solutions through its data-driven platform. This news hub offers investors and stakeholders timely access to official corporate announcements, financial updates, and strategic developments.
Bookmark this page for verified updates including earnings reports, partnership announcements, product innovations, and regulatory milestones. Our curated collection ensures you stay informed about SHCR's initiatives in personalized care technologies, population health programs, and value-based healthcare partnerships.
Discover updates across key categories: quarterly financial results, clinical protocol advancements, employer health program expansions, and platform feature launches. All content is sourced directly from Sharecare's communications to ensure accuracy and compliance with disclosure standards.
Return regularly to track SHCR's progress in transforming healthcare delivery through integrated digital solutions. For comprehensive analysis of how these developments impact the company's market position, combine this resource with Stock Titan's financial tools and research reports.
Sharecare has launched a new mindfulness-driven Diabetes Prevention Program (DPP), now recognized and approved by the CDC. This program, available to clients since January 1, 2023, integrates the CDC’s PreventT2 curriculum with Sharecare’s Eat Right Now program, aimed at reducing craving-related eating by 40%. The DPP emphasizes behavior change through mental and emotional health, offering features like coaching, a supportive community, and digital engagement tools. This marks the first CDC approval for a mindfulness-based DPP, which reflects Sharecare's commitment to holistic health solutions.
Sharecare (Nasdaq: SHCR), a leading digital health company, announced that its chairman and CEO, Jeff Arnold, will present at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023, at 5:15 p.m. PST. A live audio webcast of the event will be available for online access. Sharecare focuses on unifying health management through a comprehensive platform aimed at enhancing individual and population-wide well-being. The company is dedicated to making quality healthcare more accessible and affordable for all.
Sharecare, Inc. (Nasdaq: SHCR) reported a 9% revenue increase to $114.6 million for Q3 2022, up from $105.6 million in Q3 2021. The net loss decreased to $27.4 million from $43.1 million, marking a significant improvement. Adjusted EBITDA fell slightly to $7.2 million from $7.9 million. The company aims to hit key performance indicators with plans to provide guidance for 2023 in its upcoming Q4 results. Sharecare signed a strategic agreement with Carelon to integrate its advocacy solution, enhancing its service offerings.
On November 4, 2022, Sharecare (Nasdaq: SHCR) announced the winners of the 2022 Sharecare Awards, recognizing outstanding digital health campaigns. The awards celebrated diverse initiatives aimed at promoting health and well-being, with notable winners including South Florida PBS' Health Channel and KultureCity. The ceremony, held in collaboration with the National Academy of Television Arts & Sciences, emphasized the importance of engaging consumers in health issues such as health equity, mental health, and pandemic response. Sponsors of the event included Johnson & Johnson and Pfizer.
Sharecare (Nasdaq: SHCR) announced it will report its third quarter fiscal 2022 financial results on November 10, 2022, before the market opens. A conference call is scheduled for 8:00 a.m. EST on the same day to discuss these results. Interested participants can access the call via phone or through a live audio webcast. A replay will be available for approximately 90 days.
On September 20, 2022, Sharecare (Nasdaq: SHCR) unveiled nine innovative digital health solutions aimed at enhancing patient education and engagement. This initiative addresses emerging consumer needs and includes tools like Vital Voices, Rare Disease Roadmap, and Patient Connect, each designed to bridge gaps in healthcare access. The launch reflects Sharecare's commitment to improving the quality of care through tailored patient-provider interactions, aiming to empower individuals in managing their health effectively.
Sharecare (Nasdaq: SHCR) has received a three-year Wellness and Health Promotion Accreditation from the National Committee for Quality Assurance (NCQA), recognizing its lifestyle and disease management programs, including RealAge assessments and coaching. This accreditation underscores Sharecare's commitment to enhancing health benefits for clients and their members. NCQA's rigorous standards ensure that accredited organizations meet high performance levels in health promotion. Sharecare's accreditation complements its Population Health Program Accreditation, further solidifying its status in the digital health market.
Sharecare (Nasdaq: SHCR) has launched an enhanced version of Smart Omix, a digital clinical research platform aimed at empowering independent researchers and clinicians. This SaaS-based solution allows users to conduct decentralized research studies with ease, eliminating the need for technical expertise. The platform's user-friendly interface facilitates study management, electronic informed consent, and participant engagement. Companies like UCB have utilized Smart Omix for developing objective symptom measures in rare diseases. The initiative aims to improve access and equity in clinical research.
FAQ
What is the current stock price of Sharecare (SHCR)?
What is the market cap of Sharecare (SHCR)?
